Primary Site >> Liver Cancer

Gene >> MYL4

Journal: Expert Rev Anti Infect Ther. 2015 Mar;13(3):295-304.
Title: ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients.
Author: Gamal, Nesrine|Vitale, Giovanni|Andreone, Pietro
PMID: 25582226
Journal: J Gen Virol. 2015 Sep;96(9):2928-37.
Title: Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.
Author: Korba, Brent|Shetty, Kirti|Medvedev, Alexei|Viswanathan, Prasanth|Varghese, Rency|Zhou, Bin|Roy, Rabindra|Makambi, Kepher|Ressom, Habtom|Loffredo, Christopher A
PMID: 26296571
Journal: J Med Econ. 2016 Aug;19(8):795-805.
Title: Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Author: Saab, Sammy|Parise, Helene|Virabhak, Suchin|Wang, Alice|Marx, Steven E|Sanchez Gonzalez, Yuri|Misurski, Derek|Johnson, Scott
PMID: 27063573
Journal: Curr Med Res Opin. 2017 Jan;33(1):11-21.
Title: Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan.
Author: Igarashi, Ataru|Tang, Wentao|Guerra, Ines|Marie, Lucile|Cure, Sandrine|Lopresti, Michael
PMID: 27609424
Journal: J Virol Methods. 2017 Nov;249:31-37.
Title: Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay.
Author: Manee, Narathon|Thongbaiphet, Nipa|Pasomsub, Ekawat|Chantratita, Wasun
PMID: 28851606
Journal: Aliment Pharmacol Ther. 2018 Mar;47(5):550-562.
Title: Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.
Author: Ji, F|Wei, B|Yeo, Y H|Ogawa, E|Zou, B|Stave, C D|Li, Z|Dang, S|Furusyo, N|Cheung, R C|Nguyen, M H
PMID: 29327780